Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Lekka, Dr Bali

A review on a very common complication in our patients. Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Lekka, Dr Bali

Which aml sr pts benefit from transplant. Another role of mrd. https://pubmed.ncbi.nlm.nih.gov/29601212/?dopt=Abstract Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Lekka, Dr Bali

https://pubmed.ncbi.nlm.nih.gov/33897681/ Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Lekka, Dr Bali

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Lekka, Dr Bali

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Lekka, Dr Bali

https://ashpublications.org/blood/article-abstract/doi/10.1182/blood.2020010543/476241/CAR-HEMATOTOX-A-model-for-CAR-T-cell-related?redirectedFrom=fulltext Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Lekka, Dr Bali

With a limited follow-up, the German experience (203 pts) with SOC CAR-T cells in LBCL is in keeping with the approval trials in terms of safety, whereas our efficacy data appear to be inferior to published results. ABSTRACT EBMT AA2-2 STANDARD-OF-CARE CAR-T CELL THERAPY FOR LARGE B-CELL LYMPHOMA: REAL WORLD...

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Lekka, Dr Bali

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Lekka, Dr Bali

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Lekka

Presenter: Dr Liga Participants: Prof.Spyridonidis, Dr Tsokanas, Dr Lekka

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Lekka

Excellent review on HMA, their clinical use  and mechnisms on resistance. Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Lekka

Comprehensive excellent review https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370557/ Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Lekka

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Lekka

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Lekka

Journal of Clinical Oncology. 2021 Apr 27; National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide. Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, Brent R Logan, Farhad Khimani, Brian C Shaffer, Nirav N Shah, Alisha Mussetter,...